




























































































Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
WGU D115 OA AND PRE -ASSESSMENT LATEST 2026/2027 TEST BANK| WGU D115 ADVANCED PATHOPHYSIOLOGY OA & PA TEST BANK (BRAND NEW!!) — 200 Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Typology: Exams
1 / 103
This page cannot be seen from the preview
Don't miss anything!





























































































Subject Area Advanced Pathophysiology
Description This examination assesses the student's ability to integrate molecular, cellular, and systemic pathophysiologic mechanisms underlying major human diseases. Emphasis is placed on clinical reasoning, interpretation of diagnostic data, and understanding of therapeutic implications at an Ivy League graduate level.
Expected Grade A+
Total Questions 200
Duration 3 hours
Learning Outcomes 1. Analyze the interplay of genetic, epigenetic, and environmental factors in disease pathogenesis.
Accreditation This exam adheres to the rigorous standards of top-tier US research universities (e.g., Harvard, Stanford, MIT) and reflects the depth expected in a capstone advanced pathophysiology course.
A. Increased sympathetic activity and increased natriuretic peptide secretion B. Increased renin-angiotensin-aldosterone system activity and decreased vasopressin release C. Increased sympathetic activity and increased endothelin-1 expression D. Decreased sympathetic activity and increased nitric oxide bioavailability
Chronic heart failure leads to sustained sympathetic activation and increased endothelin-1, both of which promote vasoconstriction, afterload increase, and direct myocardial toxicity, worsening ventricular function. Option A: natriuretic peptides are compensatory and beneficial. Option B: vasopressin is typically increased, not decreased. Option D: sympathetic activity is increased, and nitric oxide bioavailability is decreased.
A. Increased synthesis of prostacyclin (PGI2) by endothelial cells B. Inhibition of antithrombin III activity C. Impaired generation of activated protein C D. Enhanced expression of thrombomodulin on endothelial cells
Hyperhomocysteinemia causes oxidative stress that damages endothelium, reducing thrombomodulin expression and impairing protein C activation. This shifts the balance toward thrombosis. Option A is incorrect because PGI2 is anti-thrombotic and its synthesis is decreased. Option B: antithrombin III is not directly inhibited by homocysteine. Option D: thrombomodulin expression is decreased, not enhanced.
A. Low serum calcium, low serum phosphate, elevated 1,25-dihydroxyvitamin D B. Low serum calcium, high serum phosphate, low 1,25-dihydroxyvitamin D C. High serum calcium, high serum phosphate, elevated PTH D. Normal serum calcium, low serum phosphate, elevated fibroblast growth factor 23
I n C K D , p h o s p h a t e r e t e n t i o n a n d d e c r e a s e d 1 ± - h y d r o x y l a s e a c t i v 1,25-dihydroxyvitamin D, causing hypocalcemia and secondary hyperparathyroidism. Option A is incorrect because phosphate is high, not low, and vitamin D is low. Option C is incorrect because calcium is low, not high. Option D describes early CKD with FGF23 elevation but is not the classic pattern of established secondary hyperparathyroidism.
A. Impaired bicarbonate secretion reduces the solubility of mucins B. Increased sodium absorption via ENaC reduces airway surface liquid volume C. Decreased chloride secretion leads to compensatory potassium efflux D. Accumulation of chloride in epithelial cells causes osmotic swelling and mucus retention
In cystic fibrosis, defective CFTR prevents chloride secretion, and ENaC activity is increased, leading to excessive sodium and water absorption from the airway surface liquid, dehydrating the mucus. Option A: bicarbonate secretion is also impaired but is not the primary cause of dehydration. Option C: potassium efflux is not a major compensatory mechanism. Option D: chloride does not accumulate; it is not secreted.
A. Increased production of advanced glycation end-products (AGEs) and activation of protein kinase C B. Decreased expression of vascular endothelial growth factor (VEGF) in podocytes C. Reduced activity of the polyol pathway in mesangial cells D. Increased synthesis of nitric oxide by endothelial cells
Hyperglycemia drives formation of AGEs and activates PKC, leading to increased p r o d u c t i o n o f T G F - ² , e x t r a c e l l u l a r m a t r i x a c c u m u l a t i o n , a n d g l o Option B: VEGF is increased in early diabetic nephropathy, not decreased. Option C: the polyol pathway is increased, not reduced, contributing to osmotic and oxidative stress. Option D: nitric oxide bioavailability is decreased due to oxidative stress.
A. Mutation in the epidermal growth factor receptor (EGFR) tyrosine kinase domain B. Translocation involving the ALK gene C. Inactivation of both RB1 and TP D. Amplification of HER2/neu
Small cell lung carcinoma is characterized by loss of RB1 and TP53 function in nearly all cases. Option A: EGFR mutations are common in non-small cell lung cancer, especially adenocarcinomas in never-smokers. Option B: ALK rearrangements are also seen in non-small cell lung cancer. Option D: HER2 amplification is more common in breast and gastric cancers.
A. Constitutive activation of MAP kinase signaling even in the absence of ligand B. Complete loss of MAP kinase signaling due to inability to hydrolyze GTP C. Enhanced degradation of Ras protein, leading to reduced signaling D. Shift from MAP kinase to JAK-STAT pathway activation
Ras with impaired GTPase activity remains in the active GTP-bound state, leading to sustained activation of downstream effectors like Raf, which then constitutively activates the MAP kinase cascade. Loss of GTPase activity does not prevent signaling; it prevents inactivation. Other pathways are not directly affected.
A. Decreased hepatic synthesis of albumin leading to reduced plasma oncotic pressure B. Increased portal venous hydrostatic pressure due to intrahepatic resistance C. Impaired renal sodium excretion due to activation of the renin-angiotensin-aldosterone system D. Leakage of lymph from the liver surface into the peritoneal cavity
In cirrhosis, fibrosis and nodule formation increase intrahepatic resistance to portal blood flow, causing portal hypertension. Elevated portal hydrostatic pressure forces fluid into the peritoneal cavity. While hypoalbuminemia and aldosterone activation contribute, the primary direct mechanism is increased hydrostatic pressure.
A. T cell receptor recognition of peptide-MHC B. Costimulatory signal required for T cell activation C. Antibody class switching in B cells D. Mast cell degranulation
CD28 on T cells binds to CD80/86 on APCs to provide the second (costimulatory) signal necessary for full T cell activation. Blocking this interaction prevents T cell activation without affecting TCR recognition (signal 1), antibody class switching, or mast cell degranulation.
A. Metformin B. Lisinopril C. Amlodipine D. Hydrochlorothiazide
Lisinopril, an ACE inhibitor, reduces angiotensin II levels, leading to decreased aldosterone secretion. Aldosterone normally promotes potassium excretion in the kidneys; its reduction causes potassium retention and hyperkalemia. Metformin, amlodipine, and hydrochlorothiazide do not typically cause hyperkalemia.
A. Increase in cAMP due to constitutive activity of Gi B. Decrease in cAMP due to preferential coupling to Gi C. No change in cAMP because Gs and Gi cancel each other D. Increase in cAMP due to uncoupling from Gs only
The mutation prevents the receptor from activating Gs, but it can still couple to Gi, which inhibits adenylyl cyclase. Thus, agonist binding leads to decreased cAMP levels. Constitutive Gi activity is not present; the effect is due to agonist-induced Gi activation.
A. Prolonged prothrombin time (PT) and normal activated partial thromboplastin time (aPTT) B. Normal PT, prolonged aPTT, and prolonged thrombin time C. Normal PT, normal aPTT, and positive assay for resistance to activated protein C D. Prolonged PT and aPTT with normal platelet count
Factor V Leiden mutation does not affect clotting factor levels; it only makes factor Va resistant to cleavage by activated protein C. Routine coagulation times (PT, aPTT) are normal because the mutation does not impair the coagulation cascade. The diagnosis is made by functional assay showing resistance to activated protein C.
A. Activation of trypsinogen within pancreatic acinar cells leads to autodigestion and release of pro-inflammatory cytokines. B. Bacterial translocation from the duodenum into the pancreatic duct triggers a neutrophil-mediated cytokine storm. C. Obstruction of the pancreatic duct by a gallstone causes ischemia-reperfusion injury and release of reactive oxygen species. D. Elevated serum triglycerides lead to free fatty acid toxicity and activation of the complement cascade.
In acute pancreatitis, premature activation of trypsinogen within acinar cells results in a u t o d i g e s t i o n a n d r e l e a s e o f c y t o k i n e s s u c h a s I L - 1 , I L - 6 , a n d T Option B is incorrect because bacterial translocation is a later complication, not the initial trigger. Option C describes gallstone-induced pancreatitis but the mechanism of SIRS is still trypsin-mediated. Option D is a risk factor but not the direct mechanism of SIRS.
A. Increased chloride secretion via the CFTR channel due to loss of regulatory inhibition. B. Complete absence of CFTR protein at the apical membrane due to defective protein folding and degradation. C. Impaired channel gating with normal protein expression at the cell surface. D. Normal CFTR function but reduced bicarbonate transport due to altered ion selectivity.
NBD1 is critical for proper folding and trafficking of CFTR; mutations affecting NBD typically cause misfolding and retention in the endoplasmic reticulum, leading to degradation and absence at the cell surface. Option A is opposite of CFTR loss-of-function. Option C describes a gating defect (e.g., G551D), not a truncation. Option D is not consistent with loss of NBD1.
A. Direct irritation of the ureteral mucosa by the rough surface of the calculus. B. Increased pressure in the renal pelvis and ureter due to obstruction, stretching smooth muscle fibers. C. Spasm of the ureteral smooth muscle distal to the calculus mediated by local prostaglandin release. D. Ischemia of the ureteral wall due to compression of blood vessels by the calculus.
The pain of ureteral colic is primarily due to distention of the renal capsule and ureteral wall from increased pressure proximal to the obstruction, activating stretch receptors. Option A contributes but is minor. Option C describes a secondary phenomenon; the primary pain is from stretching. Option D is not a major mechanism in acute obstruction.
A. Hypercalcemia due to ectopic parathyroid hormone-related protein (PTHrP) secretion. B. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) due to ectopic ADH production. C. Cushing syndrome due to ectopic ACTH secretion. D. Lambert-Eaton myasthenic syndrome (LEMS) due to autoantibodies against voltage-gated calcium channels.
SCLC is neuroendocrine-derived and frequently secretes ADH, causing SIADH. While Cushing syndrome (C) and LEMS (D) also occur in SCLC, SIADH is the most common. Hypercalcemia (A) is more typical of squamous cell carcinoma. Thus, SIADH is the best answer.
A. Production of urease, which hydrolyzes urea and increases urine pH. B. Expression of P fimbriae, which bind to digalactoside receptors on uroepithelial cells. C. Secretion of hemolysin, which lyses erythrocytes and releases iron. D. Formation of a polysaccharide capsule that resists phagocytosis.
P fimbriae (pili) allow uropathogenic E. coli to adhere to uroepithelial cells, facilitating ascent to the kidney. Urease (A) contributes to stone formation but not ascent. Hemolysin (C) aids in tissue damage but not primary ascent. Capsule (D) helps evade immune response but is not specific for ascending infection.
A. Rupture of an atherosclerotic plaque in the coronary artery leading to myocardial infarction. B. Degeneration of the tunica media with loss of smooth muscle cells and elastic fibers, leading to an intimal tear. C. Inflammation of the pericardium causing fibrinous exudate and cardiac tamponade. D. Embolization of a thrombus from the left atrial appendage to the aortic arch.
The presentation is classic for aortic dissection, which typically begins with an intimal tear in a weakened aortic wall due to medial degeneration (cystic medial necrosis). Hypertension is a major risk factor. Option A describes myocardial infarction, which does not cause tearing pain radiating to the back or pulse deficit. Option C is pericarditis, not dissection. Option D describes embolic stroke, not aortic dissection.
A. Elevated serum iron and transferrin saturation. B. Increased total iron-binding capacity (TIBC) and low transferrin saturation. C. Elevated serum ferritin and low TIBC. D. Normal serum iron and elevated hemoglobin electrophoresis.
In iron deficiency anemia, serum iron is low, TIBC is elevated (as the body tries to increase iron binding), and transferrin saturation is low. Ferritin is low. Option B matches. Option A is seen in hemochromatosis. Option C suggests iron overload. Option D is unrelated.
A. Increased atrial natriuretic peptide secretion B. D o w n r e g u l a t i o n o f ² 1 - a d r e n e r g i c r e c e p t o r s C. Activation of the renin-angiotensin-aldosterone system D. Increased vagal tone
Chronic activation of the renin-angiotensin-aldosterone system (RAAS) leads to vasoconstriction, sodium and water retention, and myocardial fibrosis, contributing to d e c o m p e n s a t i o n. A N P i s c o m p e n s a t o r y a n d p r o t e c t i v e , ² 1 d o w n r e g adaptive desensitization, and vagal tone is typically decreased in heart failure.
A. Obstructive nephropathy due to ureteral stricture B. Intrarenal reflux of infected urine causing tubulointerstitial inflammation C. Glomerular hypertension from compensatory hyperfiltration D. Ischemic injury from renal artery compression
Vesicoureteral reflux allows infected urine to ascend into the renal parenchyma, leading to pyelonephritis and tubulointerstitial scarring. Obstructive nephropathy would require physical blockage, not reflux. Glomerular hypertension is more relevant to nephron loss, and ischemic injury is not a direct consequence of reflux.
A. Low serum osmolality with high urine sodium concentration B. Elevated serum uric acid level C. Hypovolemia with low central venous pressure D. Positive response to isotonic saline infusion
Both SIADH and CSW can present with hyponatremia and high urine sodium. However, in SIADH, the patient is euvolemic or mildly hypervolemic, whereas CSW is hypovolemic. SIADH typically has low serum osmolality with inappropriately concentrated urine and high urine sodium, while CSW shows hypovolemia, low CVP, and often low uric acid. Isotonic saline worsens hyponatremia in SIADH but corrects it in CSW.
A. Increased pulmonary vascular resistance due to hypoxic vasoconstriction and vascular remodeling B. Decreased left ventricular compliance leading to backward failure C. Systemic vasodilation causing reflex tachycardia and increased preload D. Pulmonary embolism causing acute pressure overload
In COPD, chronic hypoxia leads to pulmonary vasoconstriction and vascular remodeling, increasing pulmonary vascular resistance and causing pulmonary hypertension. This chronically overloads the right ventricle, leading to hypertrophy and eventually failure. Left ventricular failure is not the primary cause, systemic vasodilation is not typical, and acute PE is not the chronic driver.